Kailera Therapeutics (NASDAQ:KLRA – Get Free Report) announced its earnings results on Wednesday. The company reported ($0.74) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.55) by $0.81, FiscalAI reports. Kailera Therapeutics Price Performance Shares of NASDAQ KLRA traded up $0.22 during mid-day trading on Wednesday, hitting $12.80. The company had […]